Women’s Heart Health

By Mirvat Alasnag, MD, FACP, FACC, FSCAI, FSCCT

Left Main Disease and Bifurcation Revascularization in Female Patients

A review of current data and female representation in clinical trials evaluating left main coronary artery disease and bifurcation lesion revascularization.

By Tara L. Jones, MD, PharmD, and Valeria Paradies, MD

Transcatheter Structural Heart Disease Interventions and Women’s Health: Review of Current Data and Future Directions

A review of sex-specific differences in patients undergoing TAVR, TEER, and LAAO and the importance of increasing female representation in clinical trials.

By Lina Ya’Qoub, MD; Nadeen N. Faza, MD; Islam Y. Elgendy, MD; and Vaikom S. Mahadevan, MD

STEMI Care and Shock in Female Patients

Measures to adopt to advance primary and secondary prevention strategies that directly target women.

By Mansi Oberoi, MD; M. Chadi Alraies, MD; and Poonam Velagapudi, MD, MS

Is There a Sex-Related Difference in Response to Renal Denervation?

What do we know, and what questions do we have?

By Zainab Dakhil, FIBMS Cardiol, FABHS Med, FIBMS Med, DM Med, DM Resp, and Sara Al Raisi, MB, BCh, BAO, MRCP(UK), FRACP, PhD

Nonatherosclerotic Cardiovascular Diseases in Women

Reviewing the clinical presentation, pathophysiology, diagnostic pathway, and treatment of MINOCA, SCAD, and microvascular dysfunction in female patients.

By Ashwini Kerkar, MD; Stephane Manzo-Silberman, MD; Nadia R. Sutton, MD, MPH; and Shrilla Banerjee, MD, FRCP, FESC

Understanding Sex Differences in Acute and Chronic Coronary Syndromes

What can imaging tell us about plaque volume and consistency?

By F. Aaysha Cader, MBBS, MD, MRCP(UK), MSc(Oxon); Rudaynah Amein Alali, MBBS, Internal Medicine Board, Interventional Cardiology Fellowship, RCPI; and Mirvat Alasnag, MD, FACP, FACC, FSCAI, FSCCT

Clinical Trial Equity: From Design and Patient Recruitment to Investigator Opportunities

A multipronged approach is required to improve gender inclusivity in clinical trials and increase female representation in academia and senior clinical roles.

By Nicola Ryan, MB, BCh, BAO, MPH, and Vinoda Sharma, FRCP

Applying Team-Based Care Delivery to Interventional Cardiology: Learnings from the 2022 MedAxiom CV APP Survey

A team-based care model that incorporates effective use of advanced practice providers can ensure access to care and enhance a program’s patient care capacity.

By Ginger Biesbrock, DSC, PA-C, FACC

An Interview With Binita Shah, MD, MS, FACC, FSCAI

Dr. Shah discusses the benefit of colchicine in cardiovascular disease, the role of diet after coronary intervention, DEI efforts in interventional cardiology, and more.